See also this year's filing and all EDGAR filings for this company.
PDF Report 0001385508_2022_Opiant_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001385508, Opiant Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 69,158,964 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 11,628 |
| 2 | PropertyPlantAndEquipmentNet | 78,107 |
| 3 | remainder_Assets | 1,179,099 |
| 4 | LiabilitiesCurrent | 6,845,558 |
| 5 | LiabilitiesNoncurrent | 673,347 |
| 6 | remainder_Liabilities | 16,069,085 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,014,344 |
| 9 | ResearchAndDevelopmentExpense | 19,662,601 |
| 10 | remainder_Expenses | 12,917,818 |
| 11 | remainder_Revenues | 40,839,783 |
| 12 | remainder_NetIncome | -12,459,506 |
| 13 | remainder_ComprehensiveNetIncome | -27,918 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 70,427,798 |
| 1 | Liabilities | 23,587,990 |
| 2 | Expenses | 44,594,763 |
| 3 | Revenues | 40,839,783 |
| 4 | StockholdersEquity | 46,839,808 |
| 5 | NetIncome | -16,214,486 |
| 6 | ComprehensiveNetIncome | -16,228,445 |
| 7 | BaseVar | 95,968,879 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.83 |
| 9 | EconomicCapitalRatio | 2.91 |